Edition:
United States

Penumbra Inc (PEN.N)

PEN.N on New York Stock Exchange

102.15USD
23 Feb 2018
Change (% chg)

$2.55 (+2.56%)
Prev Close
$99.60
Open
$99.85
Day's High
$102.15
Day's Low
$98.70
Volume
34,885
Avg. Vol
44,414
52-wk High
$116.30
52-wk Low
$74.15

Chart for

About

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address... (more)

Overall

Beta: --
Market Cap(Mil.): $3,466.83
Shares Outstanding(Mil.): 33.94
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 33.67 16.59
EPS (TTM): -- -- --
ROI: -- 14.21 35.07
ROE: -- 16.88 17.79

BRIEF-Penumbra Announces Formation of Joint Venture, MVI Health

* PENUMBRA ANNOUNCES THE FORMATION OF JOINT VENTURE, MVI HEALTH

Jan 04 2018

BRIEF-Penumbra posts Q3 revenue of $83.9 million

* Penumbra, Inc. reports third quarter 2017 financial results

Nov 07 2017

Competitors

  Price Chg
Terumo Corp (4543.T) ¥5,470 +10.00
Johnson & Johnson (JNJ.N) $132.02 +2.11
Medtronic PLC (MDT.N) $80.39 -0.02
Stryker Corporation (SYK.N) $161.70 +2.74
Boston Scientific Corporation (BSX.N) $27.20 +0.72

Earnings vs. Estimates